Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Short-Term Surgical Outcome for Vestibular Schwannoma in Sweden: A Nation-Wide Registry Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comorbidity in Multiple Sclerosis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. The Neurology of Death and the Dying Brain: A Pictorial Essay

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Effect of Home-Based High-Intensity Interval Training in Patients With Lacunar Stroke: A Randomized Controlled Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Mitotic and Proliferative Indices in WHO Grade III Meningioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Preoperative antibiotic prophylaxis regimen in brain tumour surgery in Sweden: a quasi-experimental study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Human RTEL1 associates with Poldip3 to facilitate responses to replication stress and R-loop resolution

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cost-effectiveness of stereotactic laser ablation (SLA) for brain tumors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Return to work following meningioma surgery: a Swedish nationwide registry-based matched cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Jiri Bartek
  • Petter Förander
  • Erik Thurin
  • Theresa Wangerid
  • Roger Henriksson
  • Göran Hesselager
  • Asgeir Store Jakola
Vis graf over relationer

Background: Vestibular Schwannoma (VS) is a benign neoplasm arising from the 8th cranial nerve, with surgery one of the treatment modalities. In a nation-wide registry study, we describe the baseline, treatment characteristics, and short-term outcome in patients surgically treated for VS. Methods: We performed a nationwide study with data from the Swedish Brain Tumor Registry (SBTR) for all adults diagnosed with VS 2009-2015. Patient symptoms, tumor characteristics, and postoperative complications were analyzed. Results: In total 348 patients underwent surgery for VS. Mean age was 50.6 ± 14.5 years and 165 patients (47.4%) were female. The most common symptom was focal neurological deficit (92.0%), with only 25 (7.2%) being asymptomatic prior to surgery, and 217 (63.6%) had no restriction in activity. Following surgery, 100 (28.7%) patients developed new deficit(s). In terms of postoperative complications; 11 (3.2%) had a hematoma, 35 (10.1%) an infection, 10 (2.9%) a venous thromboembolism, and 23 (6.6%) had a reoperation due to complication. There were no deaths within 30-days after surgery. When grouped according to tumor size (< 4 vs. ≥4 cm), those with ≥4 cm tumors were more often males (p = 0.02), had more often ICP related symptoms (p = 0.03) and shorter time from imaging to surgery (p < 0.01). Analysis of the younger (< 65 years) vs. elderly (≥65 years) revealed no difference in outcome except increased 1-year mortality (p = 0.002) in elderly. Conclusion: In this nation-wide registry-study, we benchmark the 30-day complication rate after VS surgery as collected by the SBTR. Further, we present the current neurosurgical outcome data from both VS smaller than 40 mm compared to larger tumors, as well as younger vs. elderly VS patients. Since surgical decision making is a careful consideration of short term risk vs. long term benefit, this information can be useful in clinical decision making.

OriginalsprogEngelsk
TidsskriftFrontiers in Neurology
Vol/bind10
Sider (fra-til)43
ISSN1664-2295
DOI
StatusUdgivet - 2019

ID: 58985598